<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">diaendo</journal-id><journal-title-group><journal-title xml:lang="ru">Сахарный диабет</journal-title><trans-title-group xml:lang="en"><trans-title>Diabetes mellitus</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0351</issn><issn pub-type="epub">2072-0378</issn><publisher><publisher-name>Endocrinology research centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/2072-0351-6027</article-id><article-id custom-type="elpub" pub-id-type="custom">diaendo-6027</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Перспективен ли тест 1,5-ангидро-D-глюцитол для контроля компенсации и лечения сахарного диабета?</article-title><trans-title-group xml:lang="en"><trans-title>Is the 1,5-anhydro-D-glucitol test a promising tool for monitoring compensation and treatment of diabetes mellitus?</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Арбузова</surname><given-names>Маргарита Ивановна</given-names></name><name name-style="western" xml:lang="en"><surname>Arbuzova</surname><given-names>Margarita Ivanovna</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ильин</surname><given-names>Александр Викторович</given-names></name><name name-style="western" xml:lang="en"><surname>Il'in</surname><given-names>Alexander Viktorovich</given-names></name></name-alternatives><email xlink:type="simple">biochem@endocrincentr.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГУ Эндокринологический научный центр, Москва</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Endocrinological Research Centre, Moscow</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2010</year></pub-date><pub-date pub-type="epub"><day>15</day><month>03</month><year>2010</year></pub-date><volume>13</volume><issue>1</issue><issue-title>№1 (2010)</issue-title><fpage>123</fpage><lpage>125</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Арбузова М.И., Ильин А.В., 2010</copyright-statement><copyright-year>2010</copyright-year><copyright-holder xml:lang="ru">Арбузова М.И., Ильин А.В.</copyright-holder><copyright-holder xml:lang="en">Arbuzova M.I., Il'in A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.dia-endojournals.ru/jour/article/view/6027">https://www.dia-endojournals.ru/jour/article/view/6027</self-uri><abstract><p>1,5-АГ может быть использован как маркер краткосрочного контроля гликемии. Будучи метаболически инертным, это вещество конкурирует с глюкозой за систему реабсорбции в почечных канальцах, и относительно стабильный уровень его в крови быстро снижается, когда величина гликемии превышает почечный порог для глюкозы. 1,5-АГ более точно, чем НbА1с и фруктозамин, отражает быстрые (2 ? 14 дней) изменения глюкозы в крови. Он также более тесно связан с резкими подъемами уровня глюкозы. Иными словами, 1,5-АГ может служить хорошим дополнением к НbА1с в деле достижения адекватного контроля гликемии у больных СД. С другой стороны, следует учитывать, что скорость экскреции 1,5-АГ зависит от величины почечного порога для глюкозы и, следовательно, существуют группы пациентов (беременные, лица с терминальной стадией почечной недостаточности), для которых использование 1,5-АГ может не иметь весомого диагностического значения</p></abstract><kwd-group xml:lang="ru"><kwd>сахарный диабет</kwd><kwd>тест</kwd><kwd>гликемия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>diabetes mellitus</kwd><kwd>test</kwd><kwd>glycemia</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text // European Heart Journal. - 2007. - Supplements, Vol. 9, Suppl. C June.</mixed-citation><mixed-citation xml:lang="en">Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text // European Heart Journal. - 2007. - Supplements, Vol. 9, Suppl. C June.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Руководство по контролю постпрандиальной гликемии. Междуна- родная Диабетическая Федерация. 2007.</mixed-citation><mixed-citation xml:lang="en">Руководство по контролю постпрандиальной гликемии. Междуна- родная Диабетическая Федерация. 2007.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Yamanoushi N., Tachibana Y., Minoda S., et al. Origin and disposal of 1,5-anhydroglucitol, a major polyol in the human body // Am. J. Physiol. - 1992. - 263. - P. 268-273.</mixed-citation><mixed-citation xml:lang="en">Yamanoushi N., Tachibana Y., Minoda S., et al. Origin and disposal of 1,5-anhydroglucitol, a major polyol in the human body // Am. J. Physiol. - 1992. - 263. - P. 268-273.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Hirano K., Ziak M., Kamoshita K.,et al. N-linked oligosaccharide processing enzyme glucosidase 11 produces 1,5-anhydrofructose as a side product. - 2000. - 10. - Р. 1283-1289.</mixed-citation><mixed-citation xml:lang="en">Hirano K., Ziak M., Kamoshita K.,et al. N-linked oligosaccharide processing enzyme glucosidase 11 produces 1,5-anhydrofructose as a side product. - 2000. - 10. - Р. 1283-1289.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Tae I. 1,5-anhydroglucitol stimulates insulin secretion in insulinoma cell lines // Teikyo Medical J. - 2001. - 24. - Р. 31-39.</mixed-citation><mixed-citation xml:lang="en">Tae I. 1,5-anhydroglucitol stimulates insulin secretion in insulinoma cell lines // Teikyo Medical J. - 2001. - 24. - Р. 31-39.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Yamanoushi N., Shiohara T., Ogata N., Nashibana Y et al. Common reabsorbtion system of 1,5-anhydro-d-glucitol, fructose, and mannose in rat renal tubule // BBA. - 1996. - 291. - P. 89-95.</mixed-citation><mixed-citation xml:lang="en">Yamanoushi N., Shiohara T., Ogata N., Nashibana Y et al. Common reabsorbtion system of 1,5-anhydro-d-glucitol, fructose, and mannose in rat renal tubule // BBA. - 1996. - 291. - P. 89-95.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Sticle D., Turk J. A kinetic mass balance model for 1,5-anhydroglucitol: application to monitoring of glycemic control // Am. J. Physiol. - 1997. - 273. - P. E. 821-830.</mixed-citation><mixed-citation xml:lang="en">Sticle D., Turk J. A kinetic mass balance model for 1,5-anhydroglucitol: application to monitoring of glycemic control // Am. J. Physiol. - 1997. - 273. - P. E. 821-830.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">McGill J.B., Cole T.G., Novatzke W., Houghton S. Circulating 1,5-anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia // Diabetes Care. - 2004. - 27. - Р. 1859-1865.</mixed-citation><mixed-citation xml:lang="en">McGill J.B., Cole T.G., Novatzke W., Houghton S. Circulating 1,5-anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia // Diabetes Care. - 2004. - 27. - Р. 1859-1865.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Stettler C., Stahl M., Alleman S. et al. Association of 1,5-anhydroglucitol and 2-th postprandial blood glucose in type 2 diabetic patients // Diabetes Care. - 2008. - 31. - Р. 1534-1535.</mixed-citation><mixed-citation xml:lang="en">Stettler C., Stahl M., Alleman S. et al. Association of 1,5-anhydroglucitol and 2-th postprandial blood glucose in type 2 diabetic patients // Diabetes Care. - 2008. - 31. - Р. 1534-1535.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Dungan K.V., Buse J.B., Largay J., Kelly M.M. 1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes // Diabetes Care. - 2006. - 29. - Р. 1214-1219.</mixed-citation><mixed-citation xml:lang="en">Dungan K.V., Buse J.B., Largay J., Kelly M.M. 1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes // Diabetes Care. - 2006. - 29. - Р. 1214-1219.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Skupien J., Klupa T., Wanic T., et al. Clinical application of 1,5-anhydroglucitol measurements in patients with hepatocyte nuclear factor-1 maturityonset diabetes of the young // Diabetes Care. - 2008. - 31. - Р. 1496-1501.</mixed-citation><mixed-citation xml:lang="en">Skupien J., Klupa T., Wanic T., et al. Clinical application of 1,5-anhydroglucitol measurements in patients with hepatocyte nuclear factor-1 maturityonset diabetes of the young // Diabetes Care. - 2008. - 31. - Р. 1496-1501.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
